FDA won petition to have ruling reconsidered

The FDA has won a petition to have the US Court of Appeals for the District of Columbia reconsider a ruling that mentally competent terminally ill patients should have access to post-Phase I investigational drugs if there are no government-approved alternatives.

You must be a registered member of MMM to post a comment.

Next Article in Legal/Regulatory